Living with type I Usher syndrome: insights from patients and their parents

被引:6
|
作者
de Climens, Aude Roborel [1 ]
Tugaut, Beatrice [2 ]
Piscopo, Andrea [3 ]
Arnould, Benoit [2 ]
Buggage, Ronald [4 ]
Brun-Strang, Catherine [3 ]
机构
[1] Sanofi, Clin Outcomes Generat, 14 Espace Henri Vallee, F-69007 Lyon, France
[2] ICON Plc, Patient Ctr Outcomes, Lyon, France
[3] Sanofi, Global HEVA Early Portfolio, Chilly Mazarin, France
[4] Sanofi, Res & Dev, Chilly Mazarin, France
关键词
Usher syndrome; qualitative research; interviews; health-related quality of life; retinitis pigmentosa; QUALITY-OF-LIFE; VISION; HEALTH; QUESTIONNAIRE; IMPACT;
D O I
10.1080/13816810.2020.1737947
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Type 1 Usher syndrome (USH1) is a rare disease and major cause of genetic deaf-blindness. Deafness is present from birth while retinitis pigmentosa (RP) which typically presents during childhood is progressive leading to blindness. The aim of this research was to develop a disease model describing USH1 symptoms and their impact on patients' lives. Materials and Methods: Qualitative interviews were conducted with patients (pediatric and adult) and parents of children and adolescents with USH1. Interviewed subjects were enrolled through ophthalmologists from specialized eye centers in the USA and in France. Trained interviewers used semi-structured techniques to elicit concepts relevant to patients and their parents. Thematic analysis of interview transcripts led to the identification of concepts which were organized to generate a disease model. Results: A total of 18 patients (7 in the US; 11 in France)- 9 adults, 4 adolescents, and 5 children- and 9 mothers were interviewed. The most cited ocular symptoms were difficulty seeing at night and loss of peripheral vision. Interviewees reported limitations on Physical (e.g. difficulty moving), Mental (e.g. fear about falling), Social (e.g. difficulty discussing disease with others) and Role (e.g. difficulties at school/work) functioning. These impacts were, when possible, mitigated by coping strategies and support (e.g. using electronic devices, having a positive/proactive attitude). Conclusions: This research provides an overview of symptoms experienced by patients with USH1 and highlights the dramatic impact these have on patients' lives, allowing the identification of concepts of importance when evaluating therapeutic treatments in development for RP.
引用
收藏
页码:240 / 251
页数:12
相关论文
共 50 条
  • [1] Living with Usher's syndrome Type 1: Development of a disease impact model from qualitative interviews with patients and their parents
    Piscopo, Andrea
    Roborel de Climens, Aude
    Brun-Strang, Catherine
    Buggage, Ronald
    Barbosa, Carla Dias
    Knoble, Naomi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [2] Clinical findings in patients with Type I and Type II Usher syndrome
    Simonelli, F
    Rinaldi, M
    Nesti, A
    Testa, F
    Fusco, R
    Torre, A
    Mazzeo, S
    deCrecchio, G
    Rinaldi, M
    Greco, GM
    Rinaldi, E
    SOE '97 - XI CONGRESS OF THE EUROPEAN SOCIETY OF OPHTHALMOLOGY, VOLS 1 AND 2, 1997, : 995 - 998
  • [3] The cochlear nuclei in two patients with Usher syndrome type I
    Wagenaar, M
    Draaijer, P
    Meek, H
    ten Donkelaar, HJ
    Wesseling, P
    Kimberling, W
    Cremers, C
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 1999, 50 (03) : 185 - 195
  • [4] Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population
    Ouyang, XM
    Yan, D
    Du, LL
    Hejtmancik, JF
    Jacobson, SG
    Nance, WE
    Li, AR
    Angeli, S
    Kaiser, M
    Newton, V
    Brown, SDM
    Balkany, T
    Liu, XZ
    HUMAN GENETICS, 2005, 116 (04) : 292 - 299
  • [5] Living with Stargardt disease: insights from patients and their parents
    de Climens, Aude Roborel
    Tugaut, Beatrice
    Barbosa, Carla Dias
    Buggage, Ronald
    Brun-Strang, Catherine
    OPHTHALMIC GENETICS, 2021, 42 (02) : 150 - 160
  • [6] Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population
    Xiao Mei Ouyang
    Denise Yan
    Li Lin Du
    J. Fielding. Hejtmancik
    Samuel G. Jacobson
    Walter E. Nance
    An Ren Li
    Simon Angeli
    Muriel Kaiser
    Valerie Newton
    Steve D. M. Brown
    Thomas Balkany
    Xue Zhong Liu
    Human Genetics, 2005, 116 : 292 - 299
  • [7] The characterisation and effect of myosin VIIa mutations in patients with Usher syndrome type I
    Payne, AM
    Upadhyaya, VJ
    Bessant, DAR
    Downes, SM
    Fitzke, FW
    Holder, GE
    Bird, AC
    Weston, MD
    Kimberling, WJ
    Bhattacharya, SS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 3719 - 3719
  • [8] Genetic heterogeneity of Usher syndrome: Analysis of 151 families with Usher type I
    Astuto, LM
    Weston, MD
    Carney, CA
    Hoover, DM
    Cremers, CWRJ
    Wagenaar, M
    Moller, C
    Smith, RJH
    Pieke-Dahl, S
    Greenberg, J
    Ramesar, R
    Jacobson, SG
    Ayuso, C
    Heckenlively, JR
    Tamayo, M
    Gorin, MB
    Reardon, W
    Kimerling, WJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (06) : 1569 - 1574
  • [9] MYO7A mutation screening in Usher syndrome type I patients from diverse origins
    Jaijo, T.
    Aller, E.
    Beneyto, M.
    Najera, C.
    Graziano, C.
    Turchetti, D.
    Seri, M.
    Ayuso, C.
    Baiget, M.
    Moreno, F.
    Morera, C.
    Perez-Garrigues, H.
    Millan, J. M.
    JOURNAL OF MEDICAL GENETICS, 2007, 44 (03) : e71
  • [10] Evidence for a fourth locus in Usher syndrome type I
    Gerber, S
    LargetPiet, D
    Rozet, JM
    Bonneau, D
    Mathieu, M
    DerKaloustian, V
    Munnich, A
    Kaplan, J
    JOURNAL OF MEDICAL GENETICS, 1996, 33 (01) : 77 - 79